Atlas Trials

A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis

Clinical trial NCT04010799 · COMPLETED

Trial details

NCT number
NCT04010799
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic FibrosisNon-Cystic Fibrosis Bronchiectasis
Start date
2019-05-27
Primary completion
2021-03-08
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.